Edwards Lifesciences (NYSE: EW) today announced data demonstrating successful patient outcomes supporting its portfolio of mitral and tricuspid therapies. One-year data from the ENCIRCLE single-arm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback